Relapsing Multiple Sclerosis: CYB704 vs. Ocrevus

We are comparing a new biosimilar treatment to Ocrevus for people with relapsing multiple sclerosis. The study aims to evaluate how well it works and its safety profile.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
University Multiprofile Hospital For Active Treatment And Emergency Medicine N I Pirogov
Nervous Diseases Clinic
Pernik, Bulgaria
Medical Center Academica 2008 EOOD
Pleven, Bulgaria
Multiprofile Hospital For Active Treatment Medical Complex Sveti Ivan Rilski EOOD
Plovdiv, Bulgaria

Sponsor: H e x a l AG
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.